4//SEC Filing
Wiley Matthew T. 4
Accession 0001104659-23-033401
CIK 0001720893other
Filed
Mar 15, 8:00 PM ET
Accepted
Mar 16, 5:58 PM ET
Size
8.2 KB
Accession
0001104659-23-033401
Insider Transaction Report
Form 4
Wiley Matthew T.
Other
Transactions
- Award
Restricted Stock Units
2023-03-15+12,000→ 12,000 total→ Common Stock (12,000 underlying) - Award
Stock Option (Right to Buy)
2023-03-15+36,000→ 36,000 totalExercise: $19.60Exp: 2033-03-15→ Common Stock (36,000 underlying)
Footnotes (3)
- [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
- [F2]The RSUs will vest and settle as to 25% of the total number of RSUs on the first anniversary of March 15, 2023 and as to 6.25% of the total number of Restricted Stock Units at the end of each successive three-month period thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.
- [F3]The option vests and becomes exercisable as to 25% of the underlying shares on the first anniversary of March 15, 2023 and the remaining 75% of the underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.
Documents
Issuer
BioXcel Therapeutics, Inc.
CIK 0001720893
Entity typeother
Related Parties
1- filerCIK 0001759703
Filing Metadata
- Form type
- 4
- Filed
- Mar 15, 8:00 PM ET
- Accepted
- Mar 16, 5:58 PM ET
- Size
- 8.2 KB